PMS9 Biologic Therapy Patterns and Associated Costs in Rheumatoid Arthritis Patients Who Initiated a Tumor Necrosis Factor Antagonist Over Two Years
Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.198
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2012
Authors
Publisher
Elsevier BV